A significant discovery in cancer research is arising with the use of VHH fragments to reactivate mutated p53. This vital malignant protector protein is frequently disabled in several types of cancer, causing https://bookmarkproduct.com/story22073294/nanobodies-restore-the-p53-protein-a-new-pathway-for-tumor-therapy